Liopa’s SRAVI lipreading app has made it through a rigorous approval process to be included in the ORCHA database. SRAVI is now listed as a ESF Tier 2A digital health app. SRAVI can be found in ORCHA’s database, in healthcare provider’s own regional listings such as Humber and North Yorkshire’s site, found at hnyhealthapps.co.uk.
ORCHA stands for the Organisation for the Review of Care and Health Apps. More than 60% of the geographies within the NHS are currently using ORCHA to ensure the safety and credibility of digital health apps that are used by patients, doctors, nurses and other healthcare workers. ORCHA enables workers in these organisations to find apps easily and quickly, while being reassured that these apps have been put through a rigorous process that certifies their safety, usability, reliability, and usefulness.
Of the 60% of the NHS regions using ORCHA, this ranges from full ICS solutions to individual trusts, PCNs, and local authorities. ORCHA’s reach extends beyond the UK as well, with some customers hailing from integrated care boards from the US and other countries.
“Being approved and listed by ORCHA is an important milestone for us, because it demonstrates the credibility of our SRAVI application,” said Liopa’s COO Richard McConnell. “We’ve worked hard to develop SRAVI into a digital health app that is safe to use in hospitals around the world, to enable people to speak who have lost the use of their voice. By making SRAVI visible in ORCHA, this hopefully means that many more patients’ lives will be improved by having access to SRAVI in their local hospitals.”
To be granted acceptance into ORCHA, the SRAVI app needed to score higher than 65% on categories including data handling, professional assurance, usability and accessibility, and safety and security. In total, the accreditation process took around a year from start to finish, and SRAVI was granted an 88% approval rating at the end of the process for the iOS version of the app, and 87% for the Android version.
More information about the SRAVI app
How the SRAVI app is used
The lip-reading app is designed to assist hospital patients to communicate with caregivers including their doctors, nurses and therapists. Voice-impaired patients include those who have undergone a tracheostomy, a common procedure required for critically unwell patients who require prolonged mechanical ventilation. These patients are rendered voiceless, as the tracheostomy tube passes through their vocal cords preventing speech, but they can move their lips normally.
SRAVI’s aim is to help patients communicate more naturally and easily, while also helping medical staff to manage their health care for the best possible outcomes. SRAVI empowers patients to take a proactive role in their care and recovery, improving their quality of life while their voice is impaired.
Evidence for the need for communication aids
Research shows that the inability to communicate during a critical care stay is a major source of morbidity – and it prolongs hospital stays. SRAVI may help patients to experience lower rates of depression, anxiety, and post-traumatic stress disorder. A further possible benefit is that the use of SRAVI reduces patient rehabilitation times. This is especially important on critical care units where beds cost approximately £2000 / day (compared to general ward beds costing about £100/day). These beds are in high demand, so freeing up capacity would allow many other patients to benefit.
Other evidence for SRAVI’s efficacy
A study was recently published by UCLAN on SRAVI, which found that it makes patients’ lives easier. The report made three main recommendations about the use of SRAVI.
- Overall, the report found that patients who meet certain criteria will get the most benefit from using SRAVI. These criteria include: having the necessary cognitive skills to understand use of the app, be oriented and in stable condition, and be able to understand English.
- This RWV finds that SRAVI can provide benefits to certain types of voice impaired patients, such as those listed above, and their family members. This in turn can improve patient recovery times and so reduce the cost of patients’ rehabilitation.
- Results indicate that use of SRAVI can be extended from ICUs to any other environment where voice impaired patients who fit the above-mentioned criteria are cared for. Thus, it is recommended that widespread use of SRAVI throughout appropriate areas of the NHS be expedited.
Find a full summary here.